The FDA has granted its Fast Track designation for the investigation of tirzepatide for the treatment of adults with obesity or who are overweight with weight-related comorbidities (including obstructive sleep apnea) to facilitate weight loss.
Read More
In a release, Amazon states that Halo Rise uses a sleep algorithm that has been trained and validated against overnight polysomnography.
Read More
Apnimed announced positive topline results from the MARIPOSA Phase 2b trial, a study of its lead drug candidate for obstructive sleep apnea.
Read More
Philips’ performance in the third quarter was impacted by continued supply chain challenges that were more significant than anticipated.
Read More
New research provides evidence that obstructive sleep apnea diagnosis can be shortened from one night or more to less than one hour—and conducted during the day.
Read More